Skip to content

A comparative study on fugal disease between conventional treatment and a new treatment of approach using 30 percent salicylic acid peel in patient with fungal disease

ASSESSING THE EFFICACY OF 30 PERCENT SALICYLIC ACID PEEL WITH 1 PERCENT TOPICAL LULICONAZOLE FOR TREATMENT OF DERMATOPHYTOSIS A RANDOMISED CONTROL TRIAL IN CHENGALPATTU TAMilNADU INDIA - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082290
Enrollment
150
Registered
2025-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: KERATOLYTICS APPLICATION: 30% salicylic acid application along with oral itraconazole local application , 0.5ml of 30percent salicylic acid application 2-3minutes for every 2weeks fo

Sponsors

dr sivaram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient aged above 18 years of age patient clinically diagnosed with dermatophytosis patient mycologically confirmed tinea by KOH mount

Exclusion criteria

Exclusion criteria: pregnant , lactation women individuals with extensive tinea corporis involving a large area of the body ( more than 10% of body surface area

Design outcomes

Primary

MeasureTime frame
mycological cure : absence of fungal hyphae on KOH mount clinical cure : complete resolution of all the clinical symptoms ( itching , scaling , erythema )Timepoint: it is assessed at baseline, week 4 , week 8

Secondary

MeasureTime frame
clinical cure : complete resolution of all the clinical symptoms ( itching , scaling , erythema ) adverse effects : measure the ocuurance of any side effects quality of life : assessed by DQLI questionaireTimepoint: it is assessed in baseline , week 4 , week 8

Countries

India

Contacts

Public Contactsivaram M

karpaga vinayaga institute of medical sciences and research institute

drdhanuk@gmail.com9566120848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026